Literature DB >> 3920460

Nd:YAG laser followed by radiation for treatment of malignant airway lesions.

P R Jain, H V Dedhia, N L Lapp, A B Thompson, J C Frich.   

Abstract

Patients with malignant obstructive airway lesions often present with total or segmental atelectasis of lung. In spite of prompt initiation of palliative external radiation alone, some patients were unable to complete the planned course of radiation therapy. Since May 1983, 17 patients with malignant obstructive endobronchial lesions have been treated by endoscopic Nd:YAG laser vaporization of the tumor. One to seven days later, fractionated external radiation therapy was initiated. Endoscopic use of the laser was repeated as needed during the course of treatment. Fifteen out of 17 patients successfully completed the planned course of therapy. The improved performance status was sustained in 13 of 15 patients for 2-13 months. A control group was selected from among patients with similarly located lesions who underwent external radiation treatment only prior to the availability of the Nd:YAG laser therapy. One patient developed radiation pneumonitis six weeks after completion of a second course of external radiation, another patient developed bronchopleural fistula after laser treatment which healed following closed chest tube drainage. The others had longer palliation of symptoms and improved quality of life. The results indicate that relief of airway obstruction by use of the Nd:YAG laser improved the patients' ability to tolerate subsequent external radiation treatment.

Entities:  

Mesh:

Year:  1985        PMID: 3920460     DOI: 10.1002/lsm.1900050107

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  2 in total

Review 1.  Palliative care in lung cancer.

Authors:  Betty Ferrell; Marianna Koczywas; Fred Grannis; Annie Harrington
Journal:  Surg Clin North Am       Date:  2011-04       Impact factor: 2.741

Review 2.  Endoscopic palliation of tracheobronchial malignancies.

Authors:  M R Hetzel; S G Smith
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.